Clinical Trials Logo
  1. Home
  2. Down Syndrome
  3. NCT05767203
  4. Details
NCT05767203 Clinical Trial

Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin

Down Syndrome Clinical Trial

— BioJeL  

Official title:
Search for Genetic Markers and Biomarkers to Follow Patients With Intellectual Disabilities of Genetic Origin and to Understand Its Origin and Associated Comorbidities

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05767203
Other study ID # BioJeL
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date December 31, 2032

Study information
Verified date March 2023
Source Institut Jerome Lejeune
Contact Sophie Durand
Phone +33156586300
Email sophie.durand@institutlejeune.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Analyze genetic and biological markers in patients with Intellectual Deficiencies (ID) of genetic origin in order to better understand the mechanisms of modified genes, cellular mechanisms, pathways involved in different disorders , complications and pathologies associated with ID of genetic origin.

Description:

Blood and skin samples will be taken from patients coming at the outpatients clinic of the Institut Jérôme Lejeune and who consent to participate to the study. Search and identification of markers will be then done from the collected samples.

Recruitment information / eligibility
Status Recruiting
Enrollment 2000
Est. completion date December 31, 2032
Est. primary completion date September 1, 2032
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patient diagnosed with an intellectual disability of genetic origin - Patient of all ages coming for consultation at the Institut Jérôme Lejeune - Patient whose parents or legal representative have received and understood the information document and signed the informed consent for a sample for the research project. - Patient affiliated to a social security scheme Exclusion Criteria: - Parents unable to find out about the constraints related to the study - Refusal of informed patient participation - Pregnant, parturient and nursing mothers - Persons deprived of their liberty by judicial or administrative decision

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Biological samplings
Blood and/or skin samples

Locations
Country Name City State
France Institut Jérôme Lejeune Paris

Sponsors (1)
Lead Sponsor Collaborator
Institut Jerome Lejeune

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Identification of biomarkers in blood Analysis of biomarkers from blood samples taken during the visit 10 years
Primary Identification of biomarkers from skin samples Analysis of biomarkers from skin samples taken during the visit 10 years
See also
  Status Clinical Trial Phase
Recruiting NCT04854122 - Blood Flow Regulation in Individuals With Down Syndrome - Training Study N/A
Completed NCT04020302 - Self-Monitoring Shopping Intervention N/A
Recruiting NCT01950624 - DS-Connect {TM}: The Down Syndrome Registry
Completed NCT04751136 - the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome Phase 2
Completed NCT04767412 - Inspiratory Muscle Training and Physical Fitness in Children With Down Syndrome Randomized Control Trial N/A
Not yet recruiting NCT04037579 - Protocol for a Non-randomized Survey in Down Syndrome People Who Practice Sports. Self and Observers´ Perception.
Completed NCT04536506 - Bobath and Vojta Therapy for DS N/A
Completed NCT02882698 - Performance Analysis in Down Syndrome on Mobile Phone N/A
Completed NCT01791725 - A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia Phase 2
Unknown status NCT01975545 - Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21 Phase 2
Completed NCT01808508 - Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome N/A
Terminated NCT00754052 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17 Phase 3
Terminated NCT00754013 - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10 Phase 3
Completed NCT01313325 - Hippotherapy to Improve the Balance of Children With Movement Disorders N/A
Completed NCT01256112 - Parent Supported Weight Reduction in Down Syndrome N/A
Completed NCT01594346 - Multicenter Vitamin E Trial in Aging Persons With Down Syndrome Phase 3
Completed NCT05343468 - Life Skills Improved in Children With Down Syndrome After Using Assistive Technology N/A
Suspended NCT05755464 - Evaluation of Patients With Down Syndrome Compliance to Dental Therapy
Recruiting NCT04022460 - Using Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD)
Completed NCT04818437 - Effect of Core Stability Exercises and Balance Training in Postural Control Among Down Syndrome N/A